Shepard M. Goldberg
Chairman at Forticell Bioscience, Inc.
Shepard M. Goldberg active positions
Companies | Position | Start | End |
---|---|---|---|
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Chairman | 2007-06-28 | - |
SMG Consulting, Inc. | Corporate Officer/Principal | 2007-12-31 | - |
Career history of Shepard M. Goldberg
Former positions of Shepard M. Goldberg
Companies | Position | Start | End |
---|---|---|---|
ECHO THERAPEUTICS, INC. | Director/Board Member | 2014-06-18 | 2017-03-20 |
Independent Dir/Board Member | 2014-06-18 | 2017-03-20 | |
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Director/Board Member | 2007-09-30 | 2010-02-03 |
Director of Finance/CFO | 2010-02-09 | - | |
President | 2010-02-03 | - | |
Hydrovalve Co., Inc. | President | - | - |
EMISPHERE TECHNOLOGIES, INC. | Chief Operating Officer | 1997-12-31 | - |
Training of Shepard M. Goldberg
Adelphi University | Masters Business Admin |
New York University Tandon School of Engineering | Undergraduate Degree |
Statistics
International
United States | 9 |
Operational
Director/Board Member | 2 |
President | 2 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
Hydrovalve Co., Inc. | |
Echo Therapeutics, Inc.
Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
SMG Consulting, Inc. |
- Stock Market
- Insiders
- Shepard M. Goldberg
- Experience